Modified peptides as therapeutic agents

Details for Australian Patent Application No. 2004200691 (hide)

Owner Amgen Inc.

Inventors Liu, Chuan-Fa; Boone, Thomas Charles; Feige, Ulrich; Cheetham, Janet C.

Agent Shelston IP

Pub. Number AU-B-2004200691

Parent 767725

Filing date 20 February 2004

Wipo publication date 18 March 2004

Acceptance publication date 29 March 2007

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

Event Publications

4 March 2004 Complete Application Filed

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2004200691

29 March 2007 Application Accepted

  Published as AU-B-2004200691

2 August 2007 Standard Patent Sealed

9 July 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 02 Sep 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

7 January 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Sep 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200692-Multi-hop Communication System, Radio Control Station, Radio Station and Multi-hop Communication Method

2004200690-Modified peptides as therapeutic agents